Logo
x

Search

Subscribe Now

Engager

Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology

Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology

  • December 21, 2020
Biocytogen Entered into an Agreement with CtM Biotech to Co-develop TCR-Mimic Antibody-Based Multi-Specific T Cell Engagers for Cancer

    Biocytogen Entered into an Agreement with CtM Biotech to Co-develop TCR-Mimic Antibody-Based Multi-Specific T Cell Engagers for Ca...

    • April 19, 2022
    Sanofi to Acquire Amunix for Transformative T-Cell Engagers and Cytokine Therapies to Treat Cancer

      Sanofi to Acquire Amunix for Transformative T-Cell Engagers and Cytokine Therapies to Treat Cancer

      • December 21, 2021
      Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology

        Merck Signs a ~$1B Pact with Janux to Develop Cancer Therapies Using T Cell Engager Technology

        • December 21, 2020
        Affimed Formed a Research Collaboration with Genentech for Novel NK Cells

          Affimed Formed a Research Collaboration with Genentech for Novel NK Cells

          • August 28, 2018
          Image

          Incisive News in 3 Shots.

          Contact Us

          Our Information

          Follow Us

          Copyright © 2025 PharmaShots - All Rights Reserved.